Cargando…

Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing

PURPOSE: A number of institutions have clinically implemented CYP2D6 genotyping to guide drug prescribing. We compared implementation strategies of early adopters of CYP2D6 testing, barriers faced by both early adopters and institutions in the process of implementing CYP2D6 testing, and approaches t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavallari, Larisa H., Van Driest, Sara L., Prows, Cynthia A., Bishop, Jeffrey R., Limdi, Nita A., Pratt, Victoria M., Ramsey, Laura B., Smith, D. Max, Tuteja, Sony, Duong, Benjamin Q., Hicks, J. Kevin, Lee, James C., Obeng, Aniwaa Owusu, Beitelshees, Amber L., Bell, Gillian C., Blake, Kathryn, Crona, Daniel J., Dressler, Lynn, Gregg, Ryan A., Hines, Lindsay J., Scott, Stuart A., Shelton, Richard C., Weitzel, Kristin Wiisanen, Johnson, Julie A., Peterson, Josh F., Empey, Philip E., Skaar, Todd C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754805/ https://www.ncbi.nlm.nih.gov/pubmed/30894703 http://dx.doi.org/10.1038/s41436-019-0484-3

Ejemplares similares

Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network
por: Duong, Benjamin Q, et al.
Publicado: (2020)

Multi-site investigation of strategies for the clinical implementation of preemptive pharmacogenetic testing
por: Duarte, Julio D., et al.
Publicado: (2021)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
por: Cavallari, LH, et al.
Publicado: (2017)

Evaluating the Extent of Reusability of CYP2C19 Genotype Data among Patients Genotyped for Antiplatelet Therapy Selection
por: Beitelshees, Amber L., et al.
Publicado: (2020)

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
por: Tuteja, Sony, et al.
Publicado: (2021)

Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
por: Salloum, Ramzi G., et al.
Publicado: (2022)

Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients
por: Ramsey, Laura B., et al.
Publicado: (2020)

CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
por: Beitelshees, Amber L., et al.
Publicado: (2022)

Implementation and utilization of genetic testing in personalized medicine
por: Abul-Husn, Noura S, et al.
Publicado: (2014)

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey
por: Owusu Obeng, Aniwaa, et al.
Publicado: (2018)

Implementing a pragmatic clinical trial to tailor opioids for acute pain on behalf of the IGNITE ADOPT PGx investigators
por: Cavallari, Larisa H., et al.
Publicado: (2022)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support
por: Overby, Casey Lynnette, et al.
Publicado: (2014)

Establishing the Value of Genomics in Medicine – The IGNITE Pragmatic Trials Network
por: Ginsburg, Geoffrey S., et al.
Publicado: (2021)

Rapid response to the alpha-1 adrenergic agent phenylephrine in the perioperative period is impacted by genomics and ancestry
por: Wenric, Stephane, et al.
Publicado: (2020)

Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series
por: Edwards, Andrea, et al.
Publicado: (2021)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
por: Aldrich, Stacey L., et al.
Publicado: (2019)

Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples
por: Davis, Brittney H., et al.
Publicado: (2019)

Evaluation of population‐level pharmacogenetic actionability in Alabama
por: Davis, Brittney H., et al.
Publicado: (2021)

Perspectives from the Society for Pediatric Research: Pharmacogenetics for Pediatricians
por: Tang Girdwood, Sonya C., et al.
Publicado: (2022)

Lessons from clinical implementation of a preemptive pharmacogenetic panel as part of a testing pilot program with an employer-sponsored medical plan
por: Norris, Madeline, et al.
Publicado: (2023)

Cypiripi: exact genotyping of CYP2D6 using high-throughput sequencing data
por: Numanagić, Ibrahim, et al.
Publicado: (2015)

Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
por: Lemke, Lauren K., et al.
Publicado: (2023)

Utilizing a Human–Computer Interaction Approach to Evaluate the Design of Current Pharmacogenomics Clinical Decision Support
por: Elchynski, Amanda L., et al.
Publicado: (2021)

Development and Analytical Validation of a 29 Gene Clinical Pharmacogenetic Genotyping Panel: Multi‐Ethnic Allele and Copy Number Variant Detection
por: Scott, Stuart A., et al.
Publicado: (2020)

Expression of E. coli FimH Enhances Trafficking of an Orally Delivered Lactobacillus acidophilus Vaccine to Immune Inductive Sites via Antigen-Presenting Cells
por: Vilander, Allison C., et al.
Publicado: (2023)

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation
por: Lau-Min, Kelsey S., et al.
Publicado: (2022)

Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
por: Cai, Anping, et al.
Publicado: (2019)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
por: Coons, James C, et al.
Publicado: (2023)

A Pharmacogenetics-Based Approach to Managing Gastroesophageal Reflux Disease: Current Perspectives and Future Steps
por: Eken, Eda, et al.
Publicado: (2023)

Local Ancestry and Clinical Cardiovascular Events Among African Americans From the Atherosclerosis Risk in Communities Study
por: Shendre, Aditi, et al.
Publicado: (2017)

Race‐based and sex‐based differences in bioactive lipid mediators after myocardial infarction
por: Halade, Ganesh V., et al.
Publicado: (2020)

278 Eight Pharmacokinetic-related Genetic Variants Were Not Associated with Bleeding from Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2023)

Tracheal Aspirate as an Alternative Biologic Sample for Pharmacogenomics Testing in Mechanically Ventilated Pediatric Patients
por: Hargreaves, Katherine A., et al.
Publicado: (2021)

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2022)

Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin
por: Tuteja, Sony, et al.
Publicado: (2018)

COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
por: Pereira, Naveen L., et al.
Publicado: (2021)

Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department
por: Ghosh, Pallavi, et al.
Publicado: (2023)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021)

Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews
por: Romagnoli, Katrina M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_o2laf1fi8clgrjvhsel8s97kd1